mPharma
Operates a network of community pharmacies and supplies medicines and ongoing patient care (Mutti programme) in several African countries.
Rounds
- $13.6M · Funding round · 2024 Sanofi Global Health Unit Impact Fund and other undisclosed investors Undisclosed round type (closed January 2024) Source
- $35M · Series D · 2022 JAM Fund, Unbound, Lux Capital, Northstar, Social Capital, Novastar, TO Ventures; Citi (debt) Series D (USD 30M equity + USD 5M debt from Citi) Source
- $17M · Series C · 2020 CDC Group (now British International Investment, lead), Novastar Ventures Source
- $9.7M · Series B · 2019 Novastar Ventures, Unbound, 4DX Ventures (investor names from aggregators) Source
- $6.6M · Series A · 2017 Golden Palm Investments, Social Capital (investor names from aggregators) Source
Markets served
Sources
- techpoint.africa/news/mpharma-series-b/
- launchbaseafrica.com/2025/09/15/mpharma-founder-gregory-rocks...
- weetracker.com/2025/09/16/mpharma-ceo-gregory-rockson-steps-down/
- crunchbase.com/organization/mpharma
- linkedin.com/company/mpharma
- linkedin.com/posts/gregory-rockson-43804449_we-announced-that...
Also in HealthTech
Profile compiled from the public sources listed above, last updated 2026-11-15. Founders can claim and complete this profile through the update form.


